VYNE Therapeutics Inc. (VYNE)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.56

0.39%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	424.00K	477.00K	14.76M	20.99M	443.00K	10.64M	4.58M	674.00K	-
Cost of Revenue	-	-	3.35M	1.39M	350.00K	-	-	-	-
Gross Profit	424.00K	477.00K	11.41M	19.60M	93.00K	10.64M	4.58M	674.00K	-
Operating Income	-29.26M	-34.30M	-68.03M	-113.47M	-76.24M	-54.53M	-29.59M	-14.33M	-4.61M
Interest Income	-	-	-	-	-	3.09M	517.00K	264.00K	-
Pretax Income	-27.87M	-33.93M	-73.78M	-255.83M	-73.70M	-51.45M	-29.08M	-14.07M	-4.61M
Net Income	-28.45M	-33.95M	-73.33M	-255.57M	-70.46M	-51.45M	-29.08M	-14.07M	-4.61M
Selling & General & Admin	13.38M	16.39M	54.48M	89.54M	22.48M	12.19M	5.17M	3.75M	1.69M
Research & Development	16.31M	18.39M	24.96M	43.53M	53.76M	52.99M	29.01M	11.26M	2.92M
Other Expenses	-	363.00K	-135.00K	1.11M	-	-	-	-	-
Operating Expenses	29.68M	34.77M	79.44M	133.08M	76.24M	65.17M	34.17M	15.01M	4.61M
Interest Expense	-	-	5.61M	4.39M	2.54M	3.09M	517.00K	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-
Cost & Expenses	29.68M	34.77M	82.79M	134.47M	76.24M	65.17M	34.17M	15.01M	4.61M
Income Tax	-	13.00K	-448.00K	-258.00K	-3.24M	3.09M	-8.00K	-	-
Shares Outstanding (Basic)	10.27M	3.19M	2.86M	1.80M	471.39K	300.95K	286.04K	160.27K	160.27K
Shares Outstanding (Diluted)	10.27M	3.19M	2.86M	1.80M	471.39K	300.95K	286.04K	160.27K	160.27K
EPS (Basic)	-2.77	-10.65	-25.65	-141.9	-149.48	-170.94	-101.65	-87.78	-28.75
EPS (Diluted)	-2.77	-10.65	-25.65	-141.9	-149.48	-170.94	-101.65	-87.78	-28.75
EBITDA	-29.26M	-34.22M	-38.94M	-251.09M	-94.08M	-54.53M	-29.59M	-14.33M	-4.61M
Depreciation & Amortization	-	72.00K	109.00K	341.00K	350.00K	22.00K	8.00K	4.00K	-